Premium
Hoth Therapeutics Inc (HOTH)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an ... Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.131 | 13.9361702128 | 0.94 | 1.29 | 0.8401 | 3206901 | 1.19934725 | CS |
| 4 | -0.059 | -5.22123893805 | 1.13 | 1.29 | 0.8401 | 1103862 | 1.16406493 | CS |
| 12 | 0.242 | 29.1917973462 | 0.829 | 3.8 | 0.7011 | 10094013 | 2.1239338 | CS |
| 26 | 0.071 | 7.1 | 1 | 3.8 | 0.6506 | 5048224 | 1.97732322 | CS |
| 52 | -0.259 | -19.4736842105 | 1.33 | 3.8 | 0.58 | 3516993 | 1.7559041 | CS |
| 156 | -13.929 | -92.86 | 15 | 40.7375 | 0.58 | 1912978 | 6.3946484 | CS |
| 260 | -102.679 | -98.9677108434 | 103.75 | 196 | 0.58 | 1897462 | 22.96379469 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
